Clinical Trial

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Study acronym: DAPTShort
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of study is to evaluate the efficacy and safety of short duration of DAPT after GENOSS® DES Implantation in patients with coronary artery disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-04; most recent amendment 2025-02-18.
Trial Details
NCT Number NCT06075420
Lead Sponsor Genoss Co., Ltd.
Conditions Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
Enrollment 1,000 participants
Start Date 2021-08-18
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-21